NeuroGeneration is a clinical stage biotechnology company with neural stem cell products targeting neurological disorders caused by cell loss or injury. Our mission is to lead the field of neural stem cell therapy for neurological disorders and become the top provider of autologous neural stem cell therapy products.
Cell therapy is the most fascinating revolution in medicine currently underway. Cell therapy results from the understanding of complex molecular biology events triggering cellular division and development. With that knowledge, NeuroGeneration's scientists have reproduced divisional cell processes of adult human neural stem cells and regulated their differentiation to generate, in vitro, several millions of functional neurons. NeuroGeneration's products can be individualized to the uniqueness of each patient's disease and immunological profile, avoiding risks of viral transmission and rejection. NeuroGeneration was founded to develop effective new therapies for patients faced with irreversible illnesses.
Michel F. Levesque, M.D. Founder, NeuroGeneration
NeuroGeneration Corporate Offices
8670 Wilshire Blvd, Suite 201
Los Angeles, CA 90211
Telephone: 310-659-3880
Facsimile: 310-659-6631
